ValiRx plc (LON:VAL – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 0.23 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 183,400 shares trading hands.
ValiRx Stock Performance
The firm’s 50 day moving average is GBX 0.16 and its 200-day moving average is GBX 0.23. The stock has a market capitalization of £1.98 million, a price-to-earnings ratio of -0.28 and a beta of 0.59. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.27 and a current ratio of 4.62.
ValiRx (LON:VAL – Get Free Report) last released its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) EPS for the quarter. The firm had revenue of GBX 3 million for the quarter. ValiRx had a negative net margin of 7,115.36% and a negative return on equity of 70.79%. Analysts forecast that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
